|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Hepatic cell proliferation plays a pivotal role in the prognosis of alcoholic hepatitis显示文摘 | Nicolas Lanthier Laura Rubbia-Brandt Nathalie Lin-Marq Sophie Clément Jean-Louis Frossard Nicolas Goossens Antoine Hadengue Laurent Spahr | 2015 | Journal of Hepatology2015，，3： | 1 |
| 2 | Collagen proportionate area correlates to hepatic venous pressure gradient in non-abstinent cirrhotic patients with alcoholic liver disease显示文摘AIM To explore the relationship between collagen proportionate area(CPA) and portal hypertension-related clinical manifestations in alcoholic liver disease(ALD).METHODS Retrospective study with chart review of patients with ALD adressed to our center between January 2012 and December 2013 for a transjugular liver biopsy(TJLB) and hepatic hemodynamic study. Patients were included if they met the following criteria:(1) Medical indication for a liver biopsy in the setting of ALD;(2) recent(< 15 d) clinical, radiological, endoscopic and biological data available; and(3) estimated follow-up of at least 6 mo. Liver tissue from cirrhotic subjects obtained from transjugular liver biopsies was stained with Picro Sirius red and computer-assisted digital image analysis to determine fibrosis density using CPA was performed. RESULTS We included 61 patients with alcoholic ALD, subdivided in 41 active alcohol drinkers and 20 durably abstinent patients. Nine healthy liver donors served as controls. Mean CPA in patients with ALD was 7.1%, with no difference between active drinkers and abstinent patients(P = 0.17). Using a fibrosis density cutoff of 5%, we observed a positive correlation between high fibrosis density and the hepatic venous pressure gradient(HVPG) only in active drinkers(P = 0.02). At 12-mo of follow-up, in the group of active alcohol drinkers, patients reaching a composite outcome showed a higher HVPG value as compared to those who did not(18.5 mm Hg vs 14.5 mm Hg P < 0.04) whereas CPA values were similar(6.9% vs 11%, P = 0.23).CONCLUSION In active alcoholic ALD, CPA correlates to portal pressure but only HVPG predicts clinical events, pointing to the role of alcohol as a modulator of portal hypertension. | Sophie Restellini Nicolas Goossens Sophie Clément Nicolas Lanthier Francesco Negro Laura Rubbia-Brandt Laurent Spahr | 2018 | World Journal of Hepatology2018，10，1： | 1 |
| 3 | Molecular prognostic prediction in liver cirrhosis显示文摘The natural history of cirrhosis varies and therefore prognostic prediction is critical given the sizable patient population. A variety of clinical prognostic indicators have been developed and enable patient risk stratification although their performance is somewhat limited especially within relatively earlier stage of disease. Molecular prognostic indicators are expected to refine the prediction,and potentially link a subset of patients with molecular targeted interventions that counteract poor prognosis. Here we overview clinical and molecular prognostic indicators in the literature,and discuss critical issues to successfully define,evaluate,and deploy prognostic indicators as clinical scores or tests. The use of liver biopsy has been diminishing due to sampling variability on fibrosis assessment and emergence of imaging- or lab testbased fibrosis assessment methods. However,recent rapid developments of genomics technologies and selective molecular targeted agents has highlighted the need for biopsy tissue specimen to explore and establish molecular information-guided personalized/stratified clinical care,and eventually achieve 'precision medicine'. | Nicolas Goossens Shigeki Nakagawa Yujin Hoshida | 2015 | World Journal of Gastroenterology2015，21，36： | 1 |
| 4 | Clinicopathological indices to predict hepatocellular carcinoma molecular classification显示文摘 | Poh Seng Tan Shigeki Nakagawa Nicolas Goossens Anu Venkatesh Tiangui Huang Stephen C. Ward Xiaochen Sun Won‐Min Song Anna Koh Claudia Canasto‐Chibuque Manjeet Deshmukh Venugopalan Nair Milind Mahajan Bin Zhang Maria Isabel Fiel Masahiro Kobayashi Hiromits | 2016 | Liver Int2016，，1： | 1 |
| 5 | 多光束光盘系统中的跨步式跳轨方案 | 谌达宇 Henk Goossens Nicolas Baumgartner 战强 | 2007 | 记录媒体技术2007，0，1： | 0 |
| 6 | Impact of direct-acting antivirals on the recurrence of hepatocellular carcinoma in chronic hepatitis C显示文摘Chronic hepatitis C virus(HCV)infection is estimated to affect 56.8 million individuals globally and is a major and independent risk factor for the development of hepatocellular carcinoma(HCC).After the introduction of safe and potent direct-acting antivirals(DAAs),capable of curing HCV infection also in patients with advanced liver disease at high risk of HCC,the beneficial effect on a de novo HCC development after viral clearance has been established.However,studies addressing the relationship between DAA-induced eradication and risk of HCC recurrence(i.e.,reappearance of HCC treated before starting antivirals)have produced contradictory data,suggesting either an increase or a decrease of HCC recurrence rate,while some report no effect of these treatments.Thus,there seems to be an unclear benefit of viral clearance in patients with a history of HCC curative treatment,where the recurrence rate remains worryingly high.This short review aims to summarize current evidence on the impact of DAAs on HCC recurrence rates,the pathogenic mechanisms and characteristics of HCC recurrence after DAA treatment,the predictors of tumor recurrence,and the impact of DAAs on overall survival. | Nikoletta M.Tagkou Nicolas Goossens Francesco Negro | 2022 | Hepatoma Research2022，8，1： | 0 |
| 7 | Recent advances in gastrointestinal cancers显示文摘Gastrointestinal cancers occur in a total of eight different locations,each of them with a different standard of care.This article is not an exhaustive review of what has been published in 2020.We have concentrated on the thirteen phase III randomized studies that are practice-changing.All these studies are oral presentations which have been given in one of the four major oncology congresses,namely American Society of Clinical Oncology(ASCO),ASCO gastrointestinal(GI),European Society of Medical Oncology(ESMO)and ESMO-GI.We provide a concise view of these major trials and their main outcomes,and put these results into context. | Natacha Bordry Christoforos Astaras Marie Ongaro Nicolas Goossens Jean Louis Frossard Thibaud Koessler | 2021 | World Journal of Gastroenterology2021，27，28： | 0 |
您所在的机构暂未开通此部分的功能，请联系管理员